Table 1.
Characteristic | Received IORT n=71 (%) |
---|---|
Median age (range) | 64 (48–92) |
Clinical Staging | |
cT1a | 2 (2.8%) |
cT1b | 18 (25%) |
cT1c | 35 (49%) |
cT2 (<3cm) | 16 (23%) |
cN0 | 71 (100%) |
Grade | |
I | 25 (35%) |
II | 24 (34%) |
III | 22 (31%) |
Markers | |
ER+ | 54 (76%) |
PR+ | 50 (70%) |
HER2+ | 8 (11%) |
ER+, PR+, HER2− | 46 (65%) |
“triple negative” | 12 (17%) |